HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
Featuring perspectives from Dr Erika Hamilton and Dr Shanu Modi, including the following topics: • Introduction (0:00) • Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Dr Modi (0:58) • Contemporary Management of HER2-Positive Metastatic Breast Cancer — Dr Hamilton (25:51) CME information and select publications (https://researchtopractice.com/GMO26/...)
▶︎
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
▶︎
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
▶︎
HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
▶︎
Indistinguishable from Magic: When Fantasy and Science Fiction Meet the Science of Medicine
▶︎
Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2
▶︎
Read the Korea Economic Daily in 30 Minutes | 20260120🌞#MorningRoutine | 8 AM Live
▶︎
Breast Cancer: Ductal Carcinoma in Situ (DCIS) EXPLAINED
▶︎
How to Build & Sell AI Agents: Ultimate Beginner’s Guide
▶︎
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
▶︎
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
▶︎
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Breast Cancer: Why Chemo Comes Before Surgery
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline
▶︎
Colorectal Cancer — Fifth Annual National General Medical Oncology Summit
▶︎
Metastatic Breast Cancer: What You Need to Know
▶︎
Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider
▶︎
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
▶︎